Mitochondrial dysfunction in bipolar disorder

Bipolar Disorders

Volumn 2, Issue 3 PART 1, 2000, Pages 180-190

  Kato, Tadafumi ^a   Kato, Nobumasa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bipolar disorder; Calcium; Genetics; Magnetic resonance spectroscopy; Mitochondrial DNA; Signal transduction; Synaptic plasticity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL; CREATINE PHOSPHATE; MITOCHONDRIAL DNA;

BASAL GANGLION; BIPOLAR DISORDER; BRAIN; GENE DELETION; GENETICS; HUMAN; MELAS SYNDROME; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; POINT MUTATION; PSYCHOLOGICAL ASPECT; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; BASAL GANGLIA; BIPOLAR DISORDER; BRAIN; CALCIUM CHANNELS; DNA, MITOCHONDRIAL; GENE DELETION; HUMANS; MELAS SYNDROME; MITOCHONDRIA; PHOSPHOCREATINE; POINT MUTATION; SIGNAL TRANSDUCTION;

EID: 0034280096     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2000.020305.x     Document Type: Article

References (87)

1. Soares JC, Mallinger AG. Intracellular phosphatidylinositol pathway abnormalities in bipolar disorder patients. Psychopharmacol Bull 1997; 33: 685-691.
2. Kato T, Takahashi S, Shioiri T, Murashita J, Hamakawa H, Inubushi T. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 1994; 31: 125-133.
3. 2+ regulation in neuronal and glial cell signaling. Brain Res Rev 1997; 26: 72-81.
4. 2+ signaling. Curr Opin Neurobiol 1998; 8: 398-404.
5. Kato T, Shioiri T, Takahashi S, Inubushi T. Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo P-31 MRS. J Affect Disord 1991; 22: 185-190.
6. 7Li magnetic resonance spectroscopy. J Affect Disord 1993; 27: 53-60.
7. Kato T, Shioiri T, Murashita J, Hamakawa H, Inubushi T, Takahashi S. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res 1994; 55: 41-50.
8. 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity. Eur Arch Psychiatry Clin Neurosci 1998; 248: 301-306.
9. Deicken RF, Fein G, Weiner MW. Abnormal frontal lobe phosphorus metabolism in bipolar disorder. Am J Psychiatry 1995; 152: 915-918.
10. 31P-MRS in bipolar disorder. Int J Neuropsychopharmacol (in press).
11. Argov Z. Functional evaluation techniques in mitochondrial disorders. Eur Neurol 1998; 39: 65-71.
12. Altshuler LL, Curran JG, Hauser P, Mintz J, Denicoff K, Post R. T2 hyperintensities in bipolar disorder; magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry 1995; 152: 1139-1144.
13. Kato T, Fujii K, Kamiya A, Kato N. White matter hyperintensity detected by magnetic resonance imaging and lithium response in bipolar disorder: a preliminary observation. Psychiatry Clin Neurosci 1999 (in press).
14. Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: analysis of their clinical and imaging. Neuroradiology 1998; 14: 1119-1137.
15. Kato T, Takahashi S, Shioiri T, Inubushi T. Brain phosphorous metabolism in depressive disorders detected by phosphorous-31 magnetic resonance spectroscopy. J Affect Disord 1992; 26: 223-230.
16. Kato T, Inubushi T, Kato N. Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci 1998; 10: 133-147.
17. 31P-MRS. Psychol Med 1995; 25: 557-566.
18. Moore CM, Christensen JD, Lafer B, Fava M, Renshaw PF. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorus-31 magnetic resonance spectroscopy study. Am J Psychiatry 1997; 154: 116-118.
19. 31P magnetic resonance spectroscopy in the frontal lobe of major depressive patients. Eur Arch Psychiatry Clin Neurosci 1998; 248: 289-295.
20. DiMauro S, Wallace DC. Mitochondrial DNA in Human Pathology. New York: Raven Press, 1993.
21. Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K. Mitochondrial genotype associated with longevity. Lancet 1998; 351: 185-186.
22. Ozawa T. Mitochondrial DNA mutations and age. Ann New York Acad Sci 1998; 854: 128-154.
23. Beal MF, Howell N, Bodis-Wollner I. Mitochondria and Free Radicals in Neurodegenerative Diseases. New York: Wiley Liss, 1997.
24. Reich T, Clayton PJ, Winokur G. Family history studies: V. The genetics of mania. Am J Psychiatry 1969; 125: 1358-1369.
25. McMahon FJ, Stine OC, Meyers DA, Simpson SG, Depaulo JR. Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet 1995; 56: 1277-1286.
26. Gershon ES, Badner JA, Detera-Wadleigh SD, Ferraro TN, Berrettini WH. Maternal inheritance and chromosome 18 allele sharing in unilineal bipolar pedigrees. Am J Med Genet 1996; 67: 202-207.
27. Kato T, Winokur G, Coryell W, Keller MB, Endicott J, Rice J. Parent-of-origin effect in the transmission of bipolar disorder. Am J Med Genet 1996; 67: 546-550.
28. Grigoroiu-Serbanescu M, Nothen M, Propping P, Poustka F, Magureanu S, Vasilescu R, Marinescu E, Ardelean V. Clinical evidence for genomic imprinting in bipolar I disorder. Acta Psychiatry Scand 1995; 92: 365-370.
29. Winokur G, Reich T. Two genetic factors in manic-depressive disease. Compr Psychiatry 1970; 11: 93-99.
30. Anderson S, Bankier AT, Barrel BG, de Bruijn MHL, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJH, Staden R, Young IG. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-465.
31. Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C, Clarke CD, McInnis MG, Simpson SG, Bieschel TS, Vishio E, Riskin K, Feilotter H, Chen E, Shen S, Folstein S, Meyers DA, Bolstein D, Marr TG, DePaulo R. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet 1995; 57: 1384-1394.
32. Nothen MM, Cichon S, Rohleder H, Hemmer S, Franzek E, Fritze J, Albus M, Borrmann-Hassenbach M, Kreiner R, Weigelt B, Minges J, Lichtermann D, Maier W, Craddock N, Fimmers R, Holler T, Baur MP, Rietschel M, Propping P. Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry 1999; 4: 76-84.
33. Grigoroiu-Serbanescu M, Martinez M, Nothern MM, Propping P, Milea S, Mihailescu R, Marinescu E. Patterns of parental transmission and familial aggregation models in bipolar affective disorder. Am J Med Genet 1998; 81: 397-404.
34. DiMauro S, Moraes CT. Mitohcondrial encephalomyopathies. Arch Neurol 1993; 50: 1197-1208.
35. Fusegi M, Gomibuti T, Mizusawa H, Iwamoto H. A case report of MELAS; on various psychiatric symptoms as acute exogenous reaction type (in Japanese). Seishin Igaka (Clin Psychiatry) 1992; 34: 703-710.
36. Wallace DC. A new manifestation of Leber's disease and a new explanation for the agency responsible for its unusual pattern of inheritance. Brain 1970; 93: 121-132.
37. Ciafaloni E, Shanske S, Apostolski S, Griggs RL, Bird TD, Sumi M, DiMauro S. Multiple deletions of mitochondrial DNA. Neurology 1991; 41: 207 (abstract).
38. Shanske AL, Shanske S, Silvestri G, Tanji K, Wertheim D, Lipper S. MELAS point mutation with unusual clinical presentation. Neuromuscular Disord 1993; 3: 191-193.
39. Stewart JB, Naylor GJ. Manic-depressive psychosis in a patient with mitochondrial myopathy - a case report. Med Sci Res 1990; 18: 265-266.
40. Suomalainen A, Majander A, Haltia M, Somer H, Lonnqvist J, Savontaus ML, Peltonen L. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 1992; 90: 61-66.
41. Sweeney MG, Bundey S, Brockington M, Poulton KR, Winer JB, Harding AE. Mitochondrial myopathy associated with sudden death in young adults and a novel mutation in the mitochondrial DNA leucine transfer RNA(UUR) gene. Q J Med 1993; 86: 709-713.
42. Onishi H, Kawanishi C, Iwasawa T, Osaka H, Hanihara T, Inoue K, Yamada Y, Kosaka K. Depressive disorder due to mitochondrial tRNALeu(UUR) mutation. Biol Psychiatry 1997; 41: 1137-1139.
43. Miyaoka H, Suzuki Y, Taniyama M, Miyaoka Y, Shishikura K, Kamijima K, Atsumi Y, Matsuoka K. Mental disorders in diabetic patients with mitochondrial transfer RNALeu(UUR) mutation at position 3243. Biol Psychiatry 1997; 42: 524-526.
44. Kato T, Takahashi Y. Deletion of leukocyte mitochondrial ' DNA in bipolar disorder. J Affect Disord 1996; 37: 67-73.
45. Nakamura K, Yasaki S, Tadokoro M, Tani H, Ogata A, Moriya N. A case of mitochondrial encephalopathy misdiagnosed as Alzheimer's disease, with various kinds of neurological and psychiatric symptoms (in Japanese). Seishin Igaku (Clinical Psychiatry) 1989; 31: 651-659.
46. Inagaki T, Ishino H, Seno H, Ohguni S, Tanaka J, Kato Y. Psychiatric symptoms in a patient with diabetes mellitus associated with point mutation in mitochondria DNA. Biol Psychiatry 1997; 42: 1067-1069.
47. Suzuki Y, Miyaoka H, Taniyama M, Atsumi Y, Hosokawa K, Tanaka Y, Asahina T, Murata C, Matsuoka K. Psychiatric disturbance in mitochondrial diabetes due to 3243 mitochondrial tRNA mutation (in Japanese). J Japan Diab Soc 1995; 38: 905-907.
48. Cassidy F, Ahearm P, Carroll BJ. Elevated frequency of diabetes mellitus in bipolar disorder. Bipolar Disord 1999; 1 (Suppl 1): 26.
49. Kato T, Winokur G, McMahon FJ, Depaulo JR, Crowe RR. Quantitative analysis of leukocyte mitochondrial DNA deletion in affective disorders. Biol Psychiatry 1997; 42: 311-316.
50. Stine OC, Luu SU, Zito M. The possible association between affective disorder and partially deleted mitochondrial DNA. Biol Psychiatry 1993; 33: 141-142.
51. Kato T, Stine OC, McMahon FJ, Crowe RR. Increased levels of a mitochondrial DNA deletion in the brains in patients with bipolar disorder. Biol Psychiatry 1997; 42: 871-875.
52. Burkhardt C, Kelly JP, Lim YH, Filley CM, Parker WD Jr. Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol 1993; 33: 512-517.
53. Cavelier L, Jazin EE, Eriksson I, Prince J, Bave U, Oreland L, Gyllensten U. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 1995; 29: 217-224.
54. Porteous WK, James AM, Sheard PW, Porteous CH, Packer HA, Hyslop SJ, Melton JV, Pang CY, Wei YH, Murphy MP. Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion. Eur J Biochem 1998; 257: 192-201.
55. Nakane J, Muramatsu T, Matsushita Y, Hasegawa Y, Matsui T, Kimura M, Higuchi S. Mitochondrial DNA mutations in tissues of patients with alcohol dependence. In: Proceeding of the 19th Japanese Society of Biological Psychiatry (in Japanese). 1997; 296.
56. 31P-MR spectroscopy. Psychol Med 1999 (in press).
57. 31P-MR spectroscopy in patients with MELAS. J Neurol Sci 1998; 155: 182-185.
58. Kogelnik AM, Lott MT, Brown MD, Navathe SB, Wallace DC. MITOMAP: a human mitochondrial genome database - 1998 update. Nucleic Acids Res 1998; 26: 112-115.
59. Kato T, Kunugi H, Nanko S, Kato N. Mitochondrial DNA polymorphisms in bipolar disorder. J Affect Disord (in press).
60. Kato T, Kato N. Mitochondrial dysfunction in bipolar disorder (manic-depressive illness) (in Japanese). Brain Sci Mental Disord (in press).
61. Tanaka M. Mitochondria and aging (in Japanese). Exp Med 1998; 16: 2293-2299.
62. Ozawa H, Saito T, Takahata N. Signal Transduction Systems in Affective Disorders. Tokyo: Springer-Verlag, 1997.
63. Yamawaki S, Kagaya A, Tawara Y, Inagaki M. Intracellular calcium signaling systems in the pathophysiology of affective disorders. Life Sci 1998; 62: 1665-1670.
64. Emamghoreishi M, Schlichter L, Li PP, Parikh S, Sen J, Kamble A, Warsh JJ. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry 1997; 154: 976-982.
65. Warsh JJ, Emamghoreishi M, Li PP. Elevated B lymphoblast resting intracellular calcium is a trait-dependent abnormality specific to bipolar I disorder. Bipolar Disord 1999; 1 (suppl 1): 57.
66. Okamoto Y, Kagaya A, Shinno H, Motohashi N, Yamawaki S. Serotonin-induced platelet calcium mobilization is enhanced in mania. Life Sci 1995; 56: 327-332.
67. Griffiths EJ, Wei SK, Haigney MC, Ocampo CJ, Stern MD, Silverman HS. Inhibition of mitochondrial calcium efflux by clonazepam in intact single rat cardiomyocytes and effects on NADH production. Cell Calcium 1997; 21: 321-329.
68. Moudy AM, Handran SD, Goldberg MP, Ruffin N, Karl I, Kranz-Eble P, DeVivo DC, Rothman SM. Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy. Proc Acad Sci USA 1995; 92: 729-733.
69. Sheehan JP, Swerdlow RH, Miller SW, Davis RE, Parks JK, Parker WD, Tuttle JB. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J Neurosci 1997; 17: 4612-4622.
70. Sweldlow RH, Parks JK, Cassarino DS, Trimmer PA, Miller SW, Maguire DJ, Sheehan JP, Maguire RS, Pattee G, Juel VC, Phillips LH, Tuttle JB, Bennett JP Jr, Davis RE, Parker WD Jr. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol 1998; 153: 135-142.
71. Sheehan JP, Swerdlow RH, Parker WD, Miller SW, Davis RE, Tuttle JB. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J Neurochem 1997; 68: 1221-1233.
72. Post RM, Weiss SR. Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: the role of serotonergic mechanisms in illness progression. Biol Psychiatry 1998; 44: 193-206.
73. Budd SL. Mechanisms of neuronal damage in brain hypoxia/ischemia: focus on the role of mitochondrial calcium accumulation. Pharmacol Ther 1998; 80: 203-229.
74. Nonaka S, Hough CJ, Chuang DM. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 1998; 95: 2642-2647.
75. Yamaji T, Kagaya A, Uchitomi Y, Yokata N, Yamawaki S. Effects of carbamazepine and sodium valproate on 5-HT-induced calcium increase in individual C6 rat glioma cells. Neuropsychobiology 1996; 34: 22-25.
76. Hough CJ, Irwin RP, Gao XM, Rogawski MA, Chuang DM. Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells. J Pharmacol Exp Ther 1996; 276: 143-149.
77. Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 1999; 274: 6039-6042.
78. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 1999; 72: 879-882.
79. 2+ fluxes. Proc Natl Acad Sci USA 1994; 91: 6569-6573.
80. Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1998; 1366: 211-223.
81. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M, Peyser CE, Pearlson GD. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 1994; 151: 687-693.
82. Figiel GS, Krishnan KR, Rao VP, Doraiswamy M, Ellinwood EH Jr, Nemeroff CB, Evans D, Boyko O. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. J Neuropsychiatry Clin Neurosci 1991; 3: 18-22.
83. Dupont RM, Jernigan TL, Heindel W. Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry 1995; 52: 747-755.
84. Smith GA, Brett CL, Church J. Effects of noradrenaline on intracellular pH in acutely dissociated adult rat hippocampal CA1 neurons. J Physiol 1998; 512: 487-505.
85. Bryan RM Jr. Cerebral blood flow and energy metabolism during stress. Am J Physiol 1990; 259: H269-280.
86. Werth JL, Thayer SA. Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J Neurosci 1994; 14: 346-356.
87. Sundaram U, Knickelbein RG, Dobbins JW. Mechanism of intestinal secretion. Effect of serotonin on rabbit ileal crypt and villus cells. J Clin Invest 1991; 87: 743-746.